Evidence map›Paper›PMID 30516034›Full record

ArticleHLA2019

Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali.

Amadou Kone, Bassirou Diarra, Keira Cohen, Seydou Diabate, Bourahima Kone, Mahamane T Diakite, Hawa Diarra, Moumine Sanogo, Antieme C G Togo, Yeya Dit Sadio Sarro and 11 more

Open access · greenAbstract read
In one paragraph

Article in HLA, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Association ofThe American journal of tropical medicine and hygiene · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Amadou KoneUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.ORCID 0000-0002-6736-3653
Bassirou DiarraUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Keira CohenJohns Hopkins University School of Medicine, Baltimore, Maryland.
Seydou DiabateUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Bourahima KoneUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Mahamane T DiakiteUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Hawa DiarraUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Moumine SanogoUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Antieme C G TogoUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Yeya Dit Sadio SarroUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Bocar BayaUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Nadie CoulibalyUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Ousmane KodioUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Chad J AchenbachNorthwestern University, Chicago, Illinois.
Robert L MurphyNorthwestern University, Chicago, Illinois.
Jane L HollNorthwestern University, Chicago, Illinois.
Sophia SiddiquiNational Institute of Allergic and Infectious Diseases, Rockville, Maryland.
Seydou DoumbiaUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
William R BishaiJohns Hopkins University School of Medicine, Baltimore, Maryland.
Souleymane DialloUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Mamoudou MaigaUniversity of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNorthwestern University · USJohns Hopkins University · USNational Institute of Allergy and Infectious Diseases · US

Funding

HIV and Mycobacterial Disease in MaliD43TW010350 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI MAIGA, ALMOUSTAPHA ISSIAKA, MURPHY, ROBERT LEO · 2016 to 2025
$3.0M
Host-Pathogen Interactions in a Failing Global lineage of MTBC:M.africanumR01AI110386 · NIAID · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI DIALLO, SOULEYMANE · 2014 to 2018
$1.2M
Improved Tools for Nontuberculous Mycobacteria Lung DiseaseK08HL139994 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI COHEN, KEIRA ALEXIS · 2018 to 2022
$794k
Strengthening Guinea-Mali Collaborative Training and Research Network for a Better Control of Emerging Viral DiseasesD71TW010428 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI BEAVOGUI, ABDOUL HABIB, DIARRA, BASSIROU · 2017 to 2017
$50k
FIC NIH HHS D43 TW010350FIC NIH HHS D71 TW010428NHLBI NIH HHS K08 HL139994NIAID NIH HHS R01 AI110386NIH HHS D43TW010350NIH HHS D71TW010428NIH HHS R01AI110386
6 · The paper itself

Abstract

Tuberculosis (TB) is caused by Mycobacterium tuberculosis complex (MTBC), however, the distribution and frequency of MTBC lineages and sublineages vary in different parts of the globe. Mycobacterium africanum, a member of MTBC is responsible for a large percentage of TB cases in West Africa, however, it is rarely identified outside of this part of the World. Whether or not differential HLA polymorphism (an important host factor) is contributing to the geographic restriction of M. africanum to West Africa is unknown. Here, we conducted a cohort study in Mali of newly diagnosed individuals with active pulmonary TB and normal healthy controls. The MTBC isolates were spoligotyped to determine the TB study groups (M. tuberculosis sensu stricto LAM10 and M. africanum), and HLA typing was performed on peripheral blood. Unlike previous reports on other populations, we found that HLA class-I alleles were significantly associated with active TB disease in this population. HLA-B alleles (B*07:02, B*08:01, B*14:02, B*15:03, B*15:10, B*18:01, B*42:01, B*42:02, B*51:01 and B*81:01) were significantly associated with M. africanum (40%-45%) and M. tuberculosis (75%) compared with healthy controls. Many HLA-A alleles (A*02:05, A*34:02, A*66:01 and A*68:02) were also associated with both TB groups (65%-70%). However, many class II HLA-DR variants were found to be associated with M. tuberculosis but not M. africanum with the exception of the DRB1*03:01, which was associated with both groups. The differential HLA distribution observed in this study might be at least partially responsible for the geographical restriction of M. africanum infections to West Africa.

Indexed as

GenotypeAdolescentAdultAgedBacterial Typing TechniquesFemaleGene FrequencyGenetic Predisposition to DiseaseHistocompatibility TestingHLA AntigensHumansMaleMaliMiddle AgedMycobacterium tuberculosisPolymorphism, GeneticHLA AntigensHLAM. africanumMalituberculosisWest Africa

Identifiers

PMID30516034
PMCPMC6333481
OpenAlexW2902965381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.